TREATMENT OF SEPSIS-INDUCED ACUTE RENAL FAILURE AND RENAL VASOCONSTRICTION AND CATECHOLAMINE-INDUCED RENAL AND MESENTERIC VASOCONSTRICTION

摘要

Methods are provided for treating sepsis/endotoxin-induced acute renalfailure, and renal vasoconstriction and catecholamine-inducedrenal and mesenteric vasoconstriction by administering to a patient atherapeutically effective amount of a composition comprising at leastone drug with Type IV phosphodiesterase inhibiting activity or any combinationthereof and a pharmaceutically acceptable carrier.